Michigan ophthalmologist finds a cure for macular degeneration
By Sarah Kuta, Ars Technicode Editor By Sarah S. KutaThe latest news in visual and ophthalmic medicine, including the latest on Alzheimer’s disease, eye surgery, and the treatment of macular disc disease.
Read moreWhat are the most exciting new discoveries in eye and ocular research?
In an effort to answer that question, we asked the world’s leading experts to weigh in on the most promising research and discoveries in the field.
Ophthalmic surgeons can often be a bit of a mystery to doctors.
In fact, one of the reasons they’re so well-known is because they’re experts at treating macular lesions that develop in patients who have already undergone the standard eye procedures like corneal surgery.
But for some patients, such as those with cataracts, the macular macula, or the portion of the retina that covers the eye’s lenses, the procedure can actually cause macular loss.
Macular degenerations are generally seen in older adults, and they can be treatable with standard treatments like cornea grafts, which are made up of a layer of cartilage that’s attached to a thin plate, and lasers that selectively penetrate the tissue to repair the damaged retina.
But they can also occur in younger patients, particularly children, and often are treated with non-standard treatments, such to use an anti-inflammatory drug or an eye mask.
In addition, there are new treatments available for some forms of macula degeneration.
One of the most notable is an antihistamine called Rimonabant, which was recently approved by the Food and Drug Administration (FDA) for the treatment and prevention of maculopathy in adults.
But because of the long history of its use in people with macular disease, the drug has not been widely adopted in the United States, and it’s not approved for use in younger people.
Instead, researchers are exploring other ways to treat macular damage, and some have tried using a combination of surgery and oculoplasty, which is a type of ocular procedure that combines the removal of a cornea and replacement of the outer layer of the eye.
The cornea is removed, and then a new layer of oculoplasties is made up from the corneocytes.
In one study published in JAMA in 2015, researchers at University of Michigan Hospital and University of Southern California found that they could treat maculitis with the combination of two types of ophthalmoscope surgery: surgery and a surgical excision.
The procedure involves removing the cornea, which normally takes a long time, and replacing it with a new one, and in this case, a lens, which can then be used to replace the damaged cornea.
In this new study, they found that ocular surgery could reduce the risk of developing macular blindness in people who have a previous history of macules.
In addition, they also found that this surgery could also help with the progression of macule retinopathy, the degenerative condition that causes macular detachment.
The researchers say their research should be helpful to other researchers in other countries.
But it’s a little difficult to say whether this will help prevent maculosis in older people, or if it’ll actually be more effective in the long term.
We’ll see what we see.
As we saw in the early years of this new era of omology, there’s a lot of work still to be done, said Dr. Daniel E. Pincus, director of the Eye Institute at the University of Illinois at Chicago.
If this new research proves to be successful in treating maculopathies in older patients, we could be seeing some new treatments in the future.